Filing Details

Accession Number:
0001209191-23-017688
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-09 20:03:41
Reporting Period:
2023-03-07
Accepted Time:
2023-03-09 20:03:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1651944 Dermtech Inc. DMTK Services-Medical Laboratories (8071) 842870849
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1807311 Claudia Ibarra C/O Dermtech, Inc.
11099 N. Torrey Pines Rd. Suite 100
La Jolla CA 92037
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-03-07 148 $4.06 157,674 No 4 S Direct
Common Stock Disposition 2023-03-07 6,943 $4.06 150,731 No 4 S Direct
Common Stock Acquisiton 2023-03-07 66,877 $0.00 217,608 No 4 A Direct
Common Stock Disposition 2023-03-08 2,525 $3.88 215,083 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 A Direct
No 4 S Direct
Footnotes
  1. The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 29, 2021.
  2. The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 23, 2022.
  3. The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. Subject to the reporting person's continued service, (i) threethirty-sixths (3/36) of the restricted stock units shall vest on June 5, 2023 and (ii) the remaining thirty-three thirty-sixths (33/36) shall vest ineleven (11) equal installments of three thirty-sixths (3/36) on the fifth day of each third month following June 5, 2023 until the final vesting date onMarch 5, 2026.
  4. The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on January 17, 2020.